U.S. Food Stock News

In April 2026, Amneal Pharmaceuticals reported positive interim Phase 4 ELEVATE-PD data showing CREXONT delivered improved “Good On” time, reduced “Off” time and better motor control for Parkinson’s patients, while reaffirming its full-year 2026 revenue outlook at US$3.05 billion to US$3.15 billion. These results support Amneal’s push into higher-value specialty neurology treatments, potentially enhancing the role of CREXONT within its broader branded portfolio. Next, we’ll examine how...

Eli Lilly (LLY) has jumped back into the spotlight after its first quarter 2026 report, as strong GLP‑1 demand and fresh FDA approvals led management to lift full year revenue and profit guidance. See our latest analysis for Eli Lilly. The share price reaction around the earnings beat and guidance raise has been positive in the very near term, with a 1 day share price return of 3.07% and 7 day share price return of 8.98%. However, the 90 day share price return of 7.74% and year to date share...

In recent months, Alvotech announced that longtime General Counsel Tanya Zharov will step down after six years, with a multi‑month transition as incoming executive Lisa Graver assumes expanded leadership responsibilities and several senior leaders relocate to Reykjavik. This combination of legal leadership change and management team relocation could influence how Alvotech manages regulatory risk, governance, and future corporate decision‑making. We’ll now examine how Graver’s expanded...

Stagwell (STGW) has attracted fresh attention after recent returns and financial figures highlighted its performance in the marketing and digital transformation space. This provides investors with an updated snapshot of growth, profitability, and current market pricing. See our latest analysis for Stagwell. Stagwell’s share price has held at US$6.36 after a mixed short term pattern, with a 1 day share price return of 1.44% and a 7 day share price return showing a 7.15% decline, while the year...

Investors may be wondering whether Axon Enterprise is attractively priced at around US$402 per share, or if the recent excitement has already been accounted for in the stock price. The share price recently closed at US$402.31, with a 1.3% gain over 7 days, a 2.5% decline over 30 days, and returns of a 28.6% decline year to date and a 36.0% decline over 1 year, set against longer term gains of 82.9% over 3 years and 198.6% over 5 years. These mixed returns have put valuation questions back on...

In late April 2026, Zimmer Biomet Holdings reported first-quarter 2026 results showing sales of US$2,086.7 million and net income of US$238.1 million, reaffirmed its full-year revenue growth guidance, detailed ongoing share repurchases totaling US$1.48 billion since 2024, and announced the departure of its CFO, with the Controller and Chief Accounting Officer appointed as interim CFO. The combination of stronger earnings, benefits from technology platforms and tariffs, continued buybacks,...

Pacira BioSciences, Inc. recently reported first-quarter 2026 results showing revenue of US$177.38 million, up from US$168.92 million a year earlier, while net income eased to US$2.92 million and diluted EPS to US$0.07. Alongside these results, the company highlighted real-world Medicare data for EXPAREL showing reduced opioid use and medical costs after outpatient hip replacements, while an activist proxy battle with DOMA Perpetual Capital Management adds a governance twist ahead of the...

Checking recent performance and basic profile With no single headline event driving attention to V2X (VVX) today, the stock’s recent move appears tied to its broader performance record and role in defense mission support services. The shares closed at US$67.74, with a 1 day return near flat, a gain of about 7% over the past week, a small decline over the past month, and a modest gain over the past 3 months. Over longer periods, V2X shows a year to date return above 20%, around 37% total...

CDW Corporation recently announced that Hang Tan joined the company on April 27, 2026, as Chief Strategy and Transformation Officer, reporting to Chair and Chief Executive Officer Christine A. Leahy and overseeing enterprise strategy, the transformation office, and corporate development. Tan’s background in reshaping technology businesses, including prior leadership roles in hybrid cloud and as-a-service models, introduces a fresh dimension to how CDW may approach its long-term strategy and...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Hess...

In April 2026, MongoDB, Inc. expanded its Irish operations with a €74 million investment to grow engineering, AI development, and operational teams by around 200 roles across Dublin and a new Cork office by 2027. This move deepens MongoDB’s role in “Applied AI,” supporting more than 65,200 global customers as they deploy secure, AI-powered applications under evolving EU data and AI regulations. We’ll now examine how MongoDB’s €74 million Irish AI investment could reshape its investment...

Equinix (NasdaqGS:EQIX) has agreed to acquire Nordic data center operator atNorth, expanding its presence and capacity in the region. The company announced a new partnership with SpinLaunch to host globally distributed teleports in Equinix data centers. The SpinLaunch partnership is expected to support the Meridian Space satellite constellation for worldwide data connectivity. For investors tracking digital infrastructure, Equinix sits at the intersection of data centers, cloud...

It looks like First Bank ( NASDAQ:FRBA ) is about to go ex-dividend in the next four days. Typically, the ex-dividend...

Some First Financial Bancorp. ( NASDAQ:FFBC ) shareholders may be a little concerned to see that the Chairman of the...

Anyone interested in Pathward Financial, Inc. ( NASDAQ:CASH ) should probably be aware that the Independent Director...

We wouldn't blame Adobe Inc. ( NASDAQ:ADBE ) shareholders if they were a little worried about the fact that Shantanu...

Universal Insurance Holdings, Inc. ( NYSE:UVE ) is about to trade ex-dividend in the next four days. The ex-dividend...

Timken (NYSE:TKR) agreed to sell its belts business to Gates Industrial in a transaction expected to close in the third quarter. The deal is intended to sharpen Timken’s focus on core operations and support margin improvement in its Industrial Motion segment. Transaction proceeds are planned to fund Timken’s broader capital allocation priorities. For you as an investor, this move sits at the intersection of two industrial names that both operate across power transmission and motion control...

For investors considering whether Intuitive Surgical at around US$457.78 is a fair deal, expensive, or potentially mispriced, this article walks through key clues in the valuation story. The stock has seen mixed recent returns, with a 5.1% decline over the last 7 days, a 1.3% gain over the last 30 days, and year to date and 1 year returns of 18.5% and 13.5% declines, while the 3 and 5 year returns sit at 50.2% and 60.2% respectively. Recent coverage has continued to focus on Intuitive...

Wondering if Acadia Healthcare Company at around US$27.85 is a bargain or a value trap? This article walks through what the current price might be implying. The stock has returned 1.7% over the past week, 16.2% over the last month, 94.9% year to date and 19.5% over the past year, while the 3 year and 5 year returns of 59.7% and 56.5% declines show that longer term holders have had a very different experience. Recent coverage has focused on Acadia Healthcare Company as a specialist in...

What the Wrigley Field deal means for Shift4 Payments stock Shift4 Payments (FOUR) is in focus after agreeing to power payments across Wrigley Field for the Chicago Cubs, extending its integrated commerce ecosystem across concessions, retail outlets, and the adjacent Gallagher Way district. For investors, this high profile venue win sits alongside an existing roster of major sports and entertainment clients, raising questions about how much value these contracts might add relative to the...

DexCom (DXCM) is back in focus after first quarter 2026 earnings, reporting revenue of US$1.19b and net income of US$199.5m, alongside reaffirmed full year revenue guidance and margin upgrades. See our latest analysis for DexCom. Despite the strong first quarter results, DexCom's recent share price performance has been soft, with a 90 day share price return of 15.41% and a 1 year total shareholder return of 24.83%. This signals fading momentum even as product launches and coverage wins...

This article examines whether Bel Fuse at around US$256.12 is still offering value or if most of the opportunity has already played out, and breaks down what the current price might be indicating. The stock has posted returns of 1.3% over 7 days, 36.2% over 30 days, 67.5% year to date and 300.3% over the past year, with a very large 5 year gain of 1,382.4% that puts recent moves into a longer-term context. Recent coverage has focused on Bel Fuse's share price performance and how investors...

Azenta has appointed Trey (William E.) Martin III as President of its Multiomics business, with former president Ginger Zhou remaining as an advisor through November 2026, and granted him 17,790 time-vested RSUs that will vest in equal annual tranches from April 2027 to April 2029. This leadership transition in a core growth area, coupled with equity-based incentives, signals how Azenta is aligning executive oversight and compensation with its long-range Multiomics ambitions. Next, we’ll...